The challenge of post-implementation surveillance for novel meningococcal vaccines.
Novel serogroup B meningococcal vaccines are currently in late stage development and may be used in mass immunisation campaigns over the coming years. This represents an exciting development in the prevention of childhood meningitis, however monitoring the impact of these vaccines on meningococcal d...
Main Authors: | Snape, MD, Medini, D, Halperin, SA, DeTora, L, Drori, J, Moxon, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.
by: Keyserling, H, et al.
Published: (2006) -
Meningococcal polysaccharide-protein conjugate vaccines.
by: Snape, MD, et al.
Published: (2005) -
Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
by: Snape, MD, et al.
Published: (2009) -
Will booster doses be required for serogroup B meningococcal vaccine?
by: McQuaid, F, et al.
Published: (2014) -
Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
by: Perrett, K, et al.
Published: (2009)